Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Tanis

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 18, 2013
Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancerL G M van der Geest, J E A Portielje, M W J M Wouters, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
European Journal of Clinical Investigation|August 23, 2002
The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentrationD G M Bloemenkamp, W P Th M Mali, B C Tanis, et al.
Prenatal Diagnosis|June 6, 2006
Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot studyP C Giordano, A Plancke, C A Van Meir, et al.
Oncology|January 1, 1992
Multicenter phase II study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2017
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancerM D Franken, E M van Rooijen, A M May, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 studyK K H Goey, S G Elias, H van Tinteren, et al.
Leukemia|January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trialA A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 18, 2013
Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancerL G M van der Geest, J E A Portielje, M W J M Wouters, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
European Journal of Clinical Investigation|August 23, 2002
The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentrationD G M Bloemenkamp, W P Th M Mali, B C Tanis, et al.
Prenatal Diagnosis|June 6, 2006
Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot studyP C Giordano, A Plancke, C A Van Meir, et al.
Oncology|January 1, 1992
Multicenter phase II study of spiroplatinB C Tanis, J B Vermorken, W W ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2017
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancerM D Franken, E M van Rooijen, A M May, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 studyK K H Goey, S G Elias, H van Tinteren, et al.
Leukemia|January 31, 2024
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trialA A van de Loosdrecht, E M P Cremers, C Alhan, et al.
Pageof 2